Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association - 1 Aug 2010

Frank-Raue K, Döhring J, Scheumann G, Rondot S, Lorenz A, Schulze E, Dralle H, Raue F, Leidig-Bruckner G

Abstract excerpt

UNLABELLED: Clinical studies are needed to classify rare and novel RET mutations associated with hereditary medullary thyroid carcinoma (MTC) into one of the clinical risk groups. Here we describe two new RET mutations/variants, R770Q and L881V, in patients with MTC and analyzed genotype-phenotyp...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Follicular
Share to Calcitonin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Neuroendocrine

Share to Goiter, Nodular

Share to Iodine Radioisotopes

Share to Proto-Oncogene Proteins c-ret

Share to Thyroid Nodule

Share to Thyroidectomy

Source

Identifiers

PMID: 20013610
DOI: 10.1055/s-0029-1241851

Genes

RET
CGA
TAT

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20013610-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.PMID 20013610Read ↗

Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma.Semantic proximity Read ↗

Medullary thyroid carcinoma.Semantic proximity Read ↗

RET Proto-Oncogene Mutational Analysis in Patients With Medullary Thyroid CarcinomaSemantic proximity Read ↗

Medullary thyroid carcinoma: recent advances and management update.Semantic proximity Read ↗

Multigenerational familial medullary thyroid cancer (FMTC): evidence for FMTC phenocopies and association with papillary thyroid cancer.Semantic proximity Read ↗

Diagnosis and treatment of medullary thyroid cancer.Semantic proximity Read ↗

Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family.Semantic proximity Read ↗

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastasesSemantic proximity Read ↗

Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.Semantic proximity Read ↗

Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition.Semantic proximity Read ↗

RET Gene Analysis in Patients with Medullary Thyroid Carcinoma.Semantic proximity Read ↗

An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.